Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
103.37
-2.46 (-2.32%)
At close: Dec 26, 2025, 4:00 PM EST
103.94
+0.57 (0.55%)
After-hours: Dec 26, 2025, 4:10 PM EST
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.22 billion as of December 26, 2025.
Market Cap
1.22B
Enterprise Value
1.18B
1-Year Change
n/a
Ranking
Category
Stock Price
$103.37
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.22B, an increase of 749.86%. That is a compound annual growth rate of 702.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 1.22B | 808.64% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |